Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Eli Lilly and Company (LLY) vs Pfizer Inc. (PFE)

Eli Lilly and Company and Pfizer Inc. are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.11T against $161.7B — 6.9× the size. Pfizer Inc. trades at the lower P/E: 37.7× against 39.7×. Eli Lilly and Company grew revenue faster over the last twelve months: 49.6% against −0.21%. Eli Lilly and Company has the higher net margin (33.5% vs 6.80%) and the higher return on invested capital (26.3% vs 6.30%). Both pay a dividend; Pfizer Inc. yields more (6.18% vs 0.72%). Across the 23 metrics below, Eli Lilly and Company leads on 13 and Pfizer Inc. on 10.

Valuation

Metric LLY PFE Drug Manufacturers General median
P/E 39.71 37.71 24.72
P/S 13.26 2.56 3.35
P/B 31.17 1.91 5.00
Price to free cash flow 51.79 16.04 17.68
EV/EBITDA 30.84 10.53 13.91
EV/Sales 13.83 3.37 3.95
Earnings yield 2.52% 2.65% 2.92%
Free cash flow yield 1.93% 6.24% 4.42%

Profitability

Metric LLY PFE Drug Manufacturers General median
Gross margin 83.40% 73.18% 72.77%
Operating margin 42.22% 21.70% 18.90%
Net margin 33.53% 6.80% 8.27%
Free cash flow margin 22.83% 17.25% 17.25%
Return on equity 102.29% 4.97% 6.97%
Return on assets 21.97% 2.13% 2.76%
Return on invested capital 26.33% 6.30% 6.30%

Growth

Metric LLY PFE Drug Manufacturers General median
Revenue growth (TTM) 49.58% (0.21%) 6.79%
EPS growth (last fiscal year) 95.99% (3.55%) —
Revenue growth, 5-year CAGR 21.58% 8.48% 3.98%
Net income growth, 5-year CAGR 27.22% (3.23%) 0.42%

Health

Metric LLY PFE Drug Manufacturers General median
Debt to equity 1.62 0.74 0.63
Current ratio 1.35 1.27 1.32
Net debt to EBITDA 1.19 2.46 1.15

Dividend

Metric LLY PFE Drug Manufacturers General median
Dividend yield 0.72% 6.18% 3.57%
Payout ratio 0.59 0.43 0.53

Size

Metric LLY PFE Drug Manufacturers General median
Market cap 1.11t 161.70b 125.91b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack